ArriVent BioPharma, Inc. AVBP
Set alert
13.35 USD 0.00 0.00%
At close
13.37 +0.02 +0.15%
Pre-market · Nov 3, 9:08 AM ET
Day range unavailable
11.36 52-week range 35.83
- YTD
- -33.65%
- 1 year
- -28.72%
- Open
- —
- Prev close
- 13.35
- Mkt cap
- 658.26M
- Vol
- 0
- Avg vol
- 1.21M
- EPS
- -3.62
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -5.64
- Beta
- 1.35
- Short ratio
- 13.52
- Inst. own
- 100.41%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 16, 2026
- 50-d avg
- 26.34
- 200-d avg
- 27.09
- 1y target
- 22.30
MAX chart
Events in this range
- Aug 11, 2025Earnings: -0.9; estimate -0.7; surprise -28.57%
- Nov 10, 2025Earnings: -0.83; estimate -0.78; surprise -6.41%
- Mar 5, 2026Earnings: -0.78; estimate -0.87; surprise 10.34%
- May 11, 2026Earnings: -0.96; estimate -0.88; surprise -9.09%
- Aug 12, 2026Earnings: -1.05; estimate -0.98732; surprise -6.35%
- Oct 7, 2026Rating: Truist Securities · Buy → Buy
- Oct 7, 2026Rating: Jones Trading · Buy → Buy
- Oct 7, 2026Rating: Citigroup · Buy → Buy
- Oct 8, 2026Rating: HC Wainwright & Co. · Buy → Buy
- Oct 16, 2026Rating: BTIG · Buy → Buy
- Oct 20, 2026Rating: B. Riley Securities · Buy → Buy
Signals (59)
| Name | Date | Ago |
|---|---|---|
| RSI: Oversold | Oct 5, 2026 | 4 weeks ago |
| SMA: Bearish | Sep 21, 2026 | 1 month ago |
| SMA: Bearish | Jul 27, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 27, 2026 | 3 months ago |
| RSI: Overbought | Jun 22, 2026 | 4 months ago |
| SMA: Bullish | May 25, 2026 | 5 months ago |
| SMA: Bearish | May 18, 2026 | 5 months ago |
| RSI: Overbought | Apr 13, 2026 | 6 months ago |
| SMA: Bullish | Mar 30, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 30, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 23, 2026 | 7 months ago |
| SMA: Bearish | Mar 16, 2026 | 7 months ago |
| SMA: Bullish | Feb 9, 2026 | 8 months ago |
| SMA: Bearish | Feb 2, 2026 | 9 months ago |
| SMA: Bullish | Jan 19, 2026 | 9 months ago |
| SMA: Bullish | Jan 12, 2026 | 9 months ago |
| SMA: Bearish | Jan 5, 2026 | 10 months ago |
| SMA: Bearish | Dec 29, 2025 | 10 months ago |
| SMA: Bullish | Nov 10, 2025 | 11 months ago |
| SMA: Bullish | Nov 10, 2025 | 11 months ago |
Newest 20 of 59.
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 22.30 +67.0% upside
Now 13.35
- Target (low)
- 15.00
- Target (mean)
- 22.30
- Target (high)
- 29.00
Ratings (0m) 11 11 buy · 0 hold · 0 sell
- Strong buy0
- Buy11
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 11
- 1 month ago 11
- 2 months ago 11
- 3 months ago 11
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.07 | -1.22 – -1.00 | -0.83 | -29.0% | 0 | 0.0% | 10 |
| Next quarter | -1.10 | -1.63 – -0.90 | -0.78 | -40.7% | 0 | 0.0% | 10 |
| Current year | -4.21 | -4.94 – -3.90 | -4.32 | +2.6% | 0 | 0.0% | 11 |
| Next year | -3.72 | -4.75 – -3.10 | -4.21 | +11.6% | 6.10M | 0.0% | 10 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 20, 2026 | B. Riley Securities | Maintained | Buy | Buy |
| Oct 16, 2026 | BTIG | Reiterated | Buy | Buy |
| Oct 8, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 7, 2026 | Citigroup | Maintained | Buy | Buy |
| Oct 7, 2026 | Jones Trading | Maintained | Buy | Buy |
| Oct 7, 2026 | Truist Securities | Maintained | Buy | Buy |
| Oct 7, 2026 | Guggenheim | Maintained | Buy | Buy |
| Oct 7, 2026 | BTIG | Maintained | Buy | Buy |
| Aug 17, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 13, 2026 | Citigroup | Maintained | Buy | Buy |
| Aug 13, 2026 | Guggenheim | Reiterated | Buy | Buy |
| Aug 13, 2026 | BTIG | Reiterated | Buy | Buy |
| May 29, 2026 | Truist Securities | Maintained | Buy | Buy |
| May 13, 2026 | Citigroup | Maintained | Buy | Buy |
| Apr 24, 2026 | Citigroup | Maintained | Buy | Buy |
| Mar 23, 2026 | B. Riley Securities | Maintained | Buy | Buy |
| Mar 6, 2026 | Oppenheimer | Reiterated | Outperform | Outperform |
| Mar 6, 2026 | Citigroup | Maintained | Buy | Buy |
| Mar 6, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Dec 23, 2025 | Cantor Fitzgerald | Initiated | — | Overweight |
| Dec 10, 2025 | BTIG | Initiated | — | Buy |
| Nov 25, 2025 | Truist Securities | Initiated | — | Buy |
| Nov 11, 2025 | Citigroup | Maintained | Buy | Buy |
| Aug 12, 2025 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 12, 2025 | Citigroup | Maintained | Buy | Buy |
| Jul 22, 2025 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 25, 2025 | Clear Street | Initiated | — | Buy |
| Jun 24, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
| Jun 24, 2025 | Guggenheim | Reiterated | Buy | Buy |
| May 20, 2025 | Jones Trading | Initiated | — | Buy |